Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.
- DOI
- 10.1136/bmjopen-2025-105790
- Published
- 2025 Nov 23
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-105790,
title = {Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.},
author = {Serna-Valverde AL and Rodriguez-Suarez E and Marks DJB and Gehrmann U and Neisen J and Clarke S and Chew TS and Cummings F and De Silva S and Gordon JN and Knight P and Limdi J and Patel K and Crooks B and Sebastian S and Polytarchou C and Hannan NRF and Moran GW},
year = {2025},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-105790},
url = {https://doi.org/10.1136/bmjopen-2025-105790}
}RIS
TY - JOUR TI - Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study. AU - Serna-Valverde AL AU - Rodriguez-Suarez E AU - Marks DJB AU - Gehrmann U AU - Neisen J AU - Clarke S AU - Chew TS AU - Cummings F AU - De Silva S AU - Gordon JN AU - Knight P AU - Limdi J AU - Patel K AU - Crooks B AU - Sebastian S AU - Polytarchou C AU - Hannan NRF AU - Moran GW PY - 2025 JO - BMJ open DO - 10.1136/bmjopen-2025-105790 UR - https://doi.org/10.1136/bmjopen-2025-105790 ER -
APA
AL, S., E, R., DJB, M., U, G., J, N., S, C., TS, C., F, C., S, D. S., JN, G., P, K., J, L., K, P., B, C., S, S., C, P., NRF, H., & GW, M. (2025). Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.. BMJ open. https://doi.org/10.1136/bmjopen-2025-105790
Source records
- pubmed · retrieved 2026-09-25T21:46:38.823Z